FDA to evaluate marijuana for potential reclassification as less dangerous drug

The review process is being completed at the request of the Drug Enforcement Agency
23 ဇွန်လ 2014
Other news

The US Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification. "FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration," FDA Press Officer Jeff Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule." (See also: Scheduling in the international drug control system)

The Huffington Post (US)
Tuesday, June 24, 2014